Home/Filings/4/0001104659-19-015345
4//SEC Filing

Bergstein Ivan 4

Accession 0001104659-19-015345

CIK 0001264587other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 9:01 PM ET

Size

8.1 KB

Accession

0001104659-19-015345

Insider Transaction Report

Form 4
Period: 2019-03-11
Bergstein Ivan
DirectorCEO, Pres., Treas., Sec.10% Owner
Transactions
  • Sale

    Common Stock

    2019-03-11$11.11/sh55,073$611,8612,664,278 total
  • Sale

    Common Stock

    2019-03-12$11.05/sh2,151$23,7692,662,127 total
Footnotes (5)
  • [F1]In connection with the vesting of 35,927 shares on March 8, 2019 and 66,571 shares on March 9, 2019, a total of 57,224 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
  • [F2]Reflects the weighted average sale price. The range of prices for such transaction is $11.00 to $11.55. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Of the 2,664,278 shares, 849,700 shares are restricted stock.
  • [F4]Reflects the weighted average sale price. The range of prices for such transaction is $11.03 to $11.25. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]Of the 2,662,127 shares, 849,700 shares are restricted stock.

Documents

1 file

Issuer

STEMLINE THERAPEUTICS INC

CIK 0001264587

Entity typeother

Related Parties

1
  • filerCIK 0001554767

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 9:01 PM ET
Size
8.1 KB